FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2479508725> ?p ?o ?g. }

• W2479508725 endingPage "1453" @default.
• W2479508725 startingPage "1445" @default.
• W2479508725 abstract "Metformin is the first-line oral antihyperglycemic of choice for individuals with type 2 diabetes. Recent evidence supports a role for metformin in prostate cancer chemoprotection. However, whether metformin indeed influences prostate biology is unknown. We aimed to study the association between metformin and serum prostate-specific antigen (PSA) levels-the primary prostate cancer biomarker.We conducted a cross-sectional study of 326 prostate cancer-free men with type 2 diabetes were recruited between 2004 and 2013 at St. Michael's Hospital. Men were excluded if they had a PSA ≥10-ng/ml, or used >2,550-mg/d metformin or supplemental androgens. Multivariate linear regressions quantified the association between metformin dose and log-PSA. Secondary analyses quantified the association between other antihyperglycemics (sulfonylureas, thiazolidinediones) and PSA; sensitivity analyses tested covariate interactions.Median PSA was 0.9-ng/ml (IQR: 0.5-1.6-ng/ml). Metformin dose associated positively with BMI, HbA1c, diabetes duration, and number of statin, acetylsalicylic acid, diuretic users, and number of antihyperglycemics used, and negatively with LDL-C. In multivariate models, PSA changed by -8% (95%CI: -13 to -2%, P = 0.011) per 500-mg/d increase in metformin. Men with diabetes for ≥6 years (n = 163) saw a greater difference in PSA per 500-mg/d metformin (-12% [95% CI: -19 to -4%, P = 0.002], P-interaction = 0.018). Serum PSA did not relate with sulfonylureas, thiazolidinediones, or total number of antihyperglycemic agents used. Our findings are limited by the cross-sectional design of this study.Metformin dose-dependently inversely associated with serum PSA, independent of other antihyperglycemic medications. Whether metformin confers a dose-dependent benefit on prostate tumorigenesis and progression warrants investigation. Prostate 76:1445-1453, 2016. © 2016 The Authors. The Prostate published by Wiley Periodicals, Inc." @default.
• W2479508725 created "2016-08-23" @default.
• W2479508725 creator A5007710281 @default.
• W2479508725 creator A5056311537 @default.
• W2479508725 creator A5056636540 @default.
• W2479508725 creator A5081688624 @default.
• W2479508725 creator A5086605329 @default.
• W2479508725 date "2016-07-12" @default.
• W2479508725 modified "2023-09-25" @default.
• W2479508725 title "The Relationship Between Metformin and Serum Prostate‐Specific Antigen Levels" @default.
• W2479508725 cites W185214937 @default.
• W2479508725 cites W1964838116 @default.
• W2479508725 cites W1965196543 @default.
• W2479508725 cites W1967242882 @default.
• W2479508725 cites W1998042325 @default.
• W2479508725 cites W2001209876 @default.
• W2479508725 cites W2010942419 @default.
• W2479508725 cites W2012385028 @default.
• W2479508725 cites W2035569239 @default.
• W2479508725 cites W2039448072 @default.
• W2479508725 cites W2052163549 @default.
• W2479508725 cites W2058725063 @default.
• W2479508725 cites W2073604382 @default.
• W2479508725 cites W2075589817 @default.
• W2479508725 cites W2082705146 @default.
• W2479508725 cites W2087424236 @default.
• W2479508725 cites W2107757112 @default.
• W2479508725 cites W2111588416 @default.
• W2479508725 cites W2129819340 @default.
• W2479508725 cites W2131793954 @default.
• W2479508725 cites W2134793522 @default.
• W2479508725 cites W2139708347 @default.
• W2479508725 cites W2143019136 @default.
• W2479508725 cites W2149179641 @default.
• W2479508725 cites W2155530804 @default.
• W2479508725 cites W2158417308 @default.
• W2479508725 cites W2161310510 @default.
• W2479508725 cites W2162300476 @default.
• W2479508725 cites W2164095876 @default.
• W2479508725 cites W2170304616 @default.
• W2479508725 cites W3135529189 @default.
• W2479508725 cites W4362207783 @default.
• W2479508725 doi "https://doi.org/10.1002/pros.23228" @default.
• W2479508725 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5053259" @default.
• W2479508725 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27403913" @default.
• W2479508725 hasPublicationYear "2016" @default.
• W2479508725 type Work @default.
• W2479508725 sameAs 2479508725 @default.
• W2479508725 citedByCount "15" @default.
• W2479508725 countsByYear W24795087252016 @default.
• W2479508725 countsByYear W24795087252017 @default.
• W2479508725 countsByYear W24795087252019 @default.
• W2479508725 countsByYear W24795087252020 @default.
• W2479508725 countsByYear W24795087252021 @default.
• W2479508725 countsByYear W24795087252022 @default.
• W2479508725 crossrefType "journal-article" @default.
• W2479508725 hasAuthorship W2479508725A5007710281 @default.
• W2479508725 hasAuthorship W2479508725A5056311537 @default.
• W2479508725 hasAuthorship W2479508725A5056636540 @default.
• W2479508725 hasAuthorship W2479508725A5081688624 @default.
• W2479508725 hasAuthorship W2479508725A5086605329 @default.
• W2479508725 hasBestOaLocation W24795087251 @default.
• W2479508725 hasConcept C121608353 @default.
• W2479508725 hasConcept C126322002 @default.
• W2479508725 hasConcept C126894567 @default.
• W2479508725 hasConcept C134018914 @default.
• W2479508725 hasConcept C143998085 @default.
• W2479508725 hasConcept C2776235491 @default.
• W2479508725 hasConcept C2777180221 @default.
• W2479508725 hasConcept C2780192828 @default.
• W2479508725 hasConcept C2780323712 @default.
• W2479508725 hasConcept C2781406297 @default.
• W2479508725 hasConcept C555293320 @default.
• W2479508725 hasConcept C71924100 @default.
• W2479508725 hasConceptScore W2479508725C121608353 @default.
• W2479508725 hasConceptScore W2479508725C126322002 @default.
• W2479508725 hasConceptScore W2479508725C126894567 @default.
• W2479508725 hasConceptScore W2479508725C134018914 @default.
• W2479508725 hasConceptScore W2479508725C143998085 @default.
• W2479508725 hasConceptScore W2479508725C2776235491 @default.
• W2479508725 hasConceptScore W2479508725C2777180221 @default.
• W2479508725 hasConceptScore W2479508725C2780192828 @default.
• W2479508725 hasConceptScore W2479508725C2780323712 @default.
• W2479508725 hasConceptScore W2479508725C2781406297 @default.
• W2479508725 hasConceptScore W2479508725C555293320 @default.
• W2479508725 hasConceptScore W2479508725C71924100 @default.
• W2479508725 hasFunder F4320334506 @default.
• W2479508725 hasIssue "15" @default.
• W2479508725 hasLocation W24795087251 @default.
• W2479508725 hasLocation W24795087252 @default.
• W2479508725 hasLocation W24795087253 @default.
• W2479508725 hasLocation W24795087254 @default.
• W2479508725 hasOpenAccess W2479508725 @default.
• W2479508725 hasPrimaryLocation W24795087251 @default.
• W2479508725 hasRelatedWork W1980188241 @default.
• W2479508725 hasRelatedWork W1992657261 @default.
• W2479508725 hasRelatedWork W2038565121 @default.
• W2479508725 hasRelatedWork W2148869351 @default.

• next